Phillip J. Ramirez

Phillip J. Ramirez serves as a key procurement lead within the National Cancer Institute, supporting the agency’s mission to accelerate cancer research through advanced computing and data infrastructure. He manages acquisitions for high-performance computing systems, genomic data processing platforms, and cloud-based research environments that enable large-scale scientific analysis. His work directly supports translational research initiatives by ensuring researchers have access to secure, scalable, and interoperable digital infrastructure. Ramirez specializes in complex IT service contracts requiring compliance with federal data security standards and research-specific workflow integrations. His primary contractor relationships center on Roche Diagnostics Corporation, a leading provider of integrated diagnostic and genomic data solutions. He frequently engages with vendors offering end-to-end computing infrastructure, data hosting, and bioinformatics platform services, prioritizing partners capable of supporting HIPAA-compliant, high-throughput research environments. His contracting patterns reflect a preference for established industry leaders with proven capabilities in managing sensitive biomedical datasets and delivering scalable cloud-native solutions. Ramirez’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic focus on technical capability and performance over socioeconomic preferences, aligning with the NCI’s need for mission-critical infrastructure that meets rigorous scientific and cybersecurity requirements. While small business participation is not formally prioritized in his portfolio, all acquisitions remain compliant with federal acquisition regulations and competitive bidding standards. His primary NAICS focus is 518210, emphasizing computing infrastructure providers and data processing services essential to modern oncology research. He procures high-capacity data storage, AI-enabled analytics platforms, secure data transfer systems, and managed cloud services tailored to genomic sequencing workflows. His technical expertise lies at the intersection of biomedical research and enterprise IT, ensuring that computational resources meet the demanding scale and precision required for precision medicine initiatives.